CTKB Stock Price, Chart, Stats & News

Cytek Biosciences, Inc.
Save
578.56M
Market cap
–
Current P/E
370.37x
Forward P/E
CTKB chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 51.84% |
Operating margin | -20.04% |
Pretax margin | -14.81% |
Net margin | -33.02% |
Effective tax rate | -122.98% |
ROA | -14.42% |
ROE | -18.01% |
D/E | 0.10x |
Interest coverage ratio | -20.99x |
CTKB valuation
P/E | – |
P/S | 2.76x |
P/B | 1.62x |
P/CF | -118.16x |
P/FCF | -63.32x |
P/OCF | -118.16x |
PEG | 0.02x |
EV multiple | -38.46x |
About
Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells.
Similar securities
Based on sector and market capitalization
Report issue











